Incannex Healthcare Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IHL.AX research report →
Price Chart
About the company
Established in Melbourne, Australia, in 2001, Incannex Healthcare Limited, which operated as Impression Healthcare Limited until its rebranding in June 2020, is dedicated to the research, development, and commercialization of pharmaceutical products and therapies derived from medicinal cannabinoids and psychedelics. Its offerings include a trio of ultrapure cannabinoid compounds: APIRx-1801 (tetrahydrocannabinol), APIRx-1802 (CBD), and APIRx-1803 (cannabigerol). The company's clinical pipeline features IHL-42X, which has concluded Phase IIa trials for obstructive sleep apnea, and Psi-GAD, currently in Phase IIa development for generalized anxiety disorder.
- CEO
- Joel Bradley Latham
- IPO
- 2007
- Employees
- 3
- HQ
- Sydney, NSW, AU
Get TickerSpark's AI analysis on IHL.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $14.26M
- P/E
- -1.59
- PEG
- -0.12
- P/S
- 639.39
- P/B
- 0.58
- EV/EBITDA
- 0.60
- Div Yield
- 0.00%
- Gross Margin
- -192.70%
- Op Margin
- -52287.74%
- Net Margin
- -74972.98%
- ROE
- -92.47%
- ROIC
- -44.41%
Latest fiscal year · YoY change
- Revenue
- $1.01M+29.6%
- Gross Profit
- $1.01M+30.6%
- Op Income
- $-17,710,255
- Net Income
- $-19,979,558-140.1%
- EPS
- $-0.01-85.7%
- OCF Growth
- -24.5%
- FCF Growth
- -28.2%
- 52W High
- $0.28
- 52W Low
- $0.04
- 50D MA
- $0.06
- 200D MA
- $0.10
- Beta
- 2.09
- RSI (14)
- 31
- Avg Volume
- 6.43M
No earnings-call transcripts are available for IHL.AX yet.
- Free Float
- 17.1%
- Shares Outstanding
- 347.71M
- Float Shares
- 271.42M
Held by 2 ETFs
Biggest fund positions in IHL.AX by dollar value.
Our IHL.AX coverage
Recent articles, reports, and earnings notes.
No research on IHL.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IHL.AX report →